Back to Search
EVGENIA RAICHLIN, MD
MD
Cardiovascular Disease Physician
NPI: 1700907540IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
73455(WI)
CMS Specialties
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1983
Research & Publications (15)
Combined heart and liver transplantation: a single-center experience.
PMID 19623017·Transplantation·2009
8-other
Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients.
PMID 19383734·Eur Heart J·2009
4-observational
Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
PMID 19332257·J Heart Lung Transplant·2009
8-other
Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality.
PMID 19067662·Am J Transplant·2009
8-other
Proliferation signal inhibitors and cardiac allograft vasculopathy.
PMID 19060540·Curr Opin Organ Transplant·2008
6-review
Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft.
PMID 19034009·Transplantation·2008
3-trial
Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
PMID 18408575·Transplantation·2008
8-other
Features of cardiac allograft coronary endothelial dysfunction.
PMID 19361606·Am J Cardiol·2009
8-other
Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
PMID 19358941·J Am Coll Cardiol·2009
8-other
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients.
PMID 18790727·Eur Heart J·2008
8-other
Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis.
PMID 18695150·Hypertension·2008
2-rct
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
PMID 18025531·Circulation·2007
3-trial
Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
PMID 17713429·Transplantation·2007
3-trial
Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
PMID 17692787·J Heart Lung Transplant·2007
8-other
Refractoriness and conduction interaction during modulation of non-ischemic ventricular fibrillation by flecainide.
PMID 14574082·Cardiovasc Drugs Ther·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9200 W WISCONSIN AVE, DIVISION OF CARDIOVASCULAR MEDICINE
MILWAUKEE, WI 53226 - Phone
- (414) 955-6777
Quick Facts
- NPI
- 1700907540
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 15
Are you this provider?
Claim Your Profile